229
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of Health-Related Quality of Life in Women with Community-Acquired Urinary Tract Infections Using the EQ-5D-3L in Saudi Arabia

ORCID Icon
Pages 2419-2426 | Published online: 04 Dec 2020

References

  • Alanazi MQ. An evaluation of community-acquired urinary tract infection and appropriateness of treatment in an emergency department in Saudi Arabia. Ther Clin Risk Manag. 2018;14:2363–2373. doi:10.2147/TCRM.S178855
  • François M, Hanslik T, Dervaux B, et al. The economic burden of urinary tract infections in women visiting general practices in France: a cross-sectional survey. BMC Health Serv Res. 2016;16(a):365. doi:10.1186/s12913-016-1620-2
  • Kalyanaraman R, Demtchouk V, Iyer V, Patterson D. Determining the health state utility value of urinary tract infection in Women. Female Pelvic Med Reconstr Surg. 2019;25(2):185–187. doi:10.1097/SPV.0000000000000696
  • Alanazi MQ, Al-Jeraisy MI, Salam M. Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia. Drug Healthc Patient Saf. 2015;7:103–111.
  • Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob. 2018;17(1):3. doi:10.1186/s12941-018-0255-z
  • Alanazi MQ, Salam M, Alqahtani FY, et al. An evaluation of antibiotics prescribing patterns in the emergency department of a tertiary care hospital in Saudi Arabia. Infect Drug Resist. 2019;12:3241–3247. doi:10.2147/IDR.S211673
  • Alshayban D, Joseph R. Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: a cross-sectional study. PLoS One. 2020;15(1):e0227573.
  • Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–629. doi:10.7326/0003-4819-118-8-199304150-00009
  • The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi:10.1016/0168-8510(90)90421-9
  • Cabasés J, In: RR. Introduction. In: Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective Based on EQ-5D. Dordrecht: Springer; 2014:1–6.
  • Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health‐related quality of life: an EQ‐5D‐5L value set for England. Health Econ. 2018;27:7–22. doi:10.1002/hec.3564
  • Wisloff T, Hagen G, Hamidi V, Movik E, Klemp M, Olsen JA. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010. Pharmacoeconomics. 2014;32:367–375. doi:10.1007/s40273-014-0136-z
  • Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127–137. doi:10.1007/s40258-017-0310-5
  • Rupel VP, Crosswalk OM. EQ-5D-5L value set for Slovenia. Slovenian J Public Health. 2020;59(3):189–194. doi:10.2478/sjph-2020-0024
  • Harvie HS, Shea JA, Andy UU, Propert K, Schwartz JS, Arya LA. Validity of utility measures for women with urge, stress, and mixed urinary incontinence. Am J Obstet Gynecol. 2014;210(1):85–e1. doi:10.1016/j.ajog.2013.09.025
  • EuroQol Research foundation. EQ-5D-3L user Guide. Available from: https://euroqol.org. Accessed November 24, 2020.
  • Van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715. doi:10.1016/j.jval.2012.02.008
  • Sanyal C, Husereau DR, Beahm NP, Smyth D, Tsuyuki RT. Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists. BMC Health Serv Res. 2019;19(1):499. doi:10.1186/s12913-019-4303-y
  • Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health‐related quality of life. BJU Int. 2012;110(11c):E830–6. doi:10.1111/j.1464-410X.2012.11337.x
  • Gerlinger C, Bamber L, Leverkus F, et al. Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results. BMC Res Notes. 2019;12(1):1–6.
  • Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T. Costs and net health effects of contraceptive methods. Contraception. 2004;69:447–459. doi:10.1016/j.contraception.2004.03.008
  • Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women’s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45. doi:10.1186/1477-7525-3-45
  • Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13:392–397. doi:10.3122/15572625-13-6-392
  • Abrahamian FM, Krishnadasan A, Mower WR, Moran GJ, Coker JR, Talan DA. The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis. Infection. 2011;39:507–514. doi:10.1007/s15010-011-0163-z
  • Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect. 2001;48:33–42. doi:10.1053/jhin.2001.0938
  • Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107–117. doi:10.1080/14737167.2017.1359543
  • Xu RH, Cheung AW, Wong EL. Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China. Patient Prefer Adherence. 2017;11:1565. doi:10.2147/PPA.S143944
  • Bonkat G, Pickard R, Bartoletti R, et al. EAU guidelines on urological infections; 2017 [ cited April 27, 2017]. Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Urological-Infections-v2.pdf. Accessed November 24, 2020.
  • Ochoa-Brust GJ, Fernández AR, Villanueva-Ruiz GJ, et al. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86:783–787. doi:10.1080/00016340701273189